Semin Neurol 2011; 31(4): 361-373
DOI: 10.1055/s-0031-1293535
© Thieme Medical Publishers

Neuroimaging during Pregnancy

Joshua P. Klein1 , 2 , Liangge Hsu1
  • 1Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
  • 2Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
Further Information

Publication History

Publication Date:
23 November 2011 (online)

ABSTRACT

Pregnancy can be associated with a wide variety of neurologic problems, resulting from alterations in physiology of the pregnant state. The pregnant patient presenting with neurologic symptoms poses both diagnostic and therapeutic challenges. The physician will often require some form of neuroimaging as part of their ongoing evaluation. This review discusses potential risks to the embryo and fetus that can be caused by undergoing computed tomography (CT) and magnetic resonance imaging (MRI), including those associated with the administration of intravenous contrast. Neurologic diseases or syndromes specifically associated with pregnancy are also discussed.

REFERENCES

  • 1 American College of Radiology (ACR) .ACR Guidelines and Technical Standards. Practice guideline for imaging pregnant or potentially pregnant adolescents and women with ionizing radiation. 1st ed. Reston, VA: American College of Radiology; 2008: 1-15
  • 2 American College of Radiology. ACR practice guideline for the use of intravascular contrast media. Reston, VA: American College of Radiology; 2007: 1-6
  • 3 Kanal E, Barkovich A J, Bell C ACR Blue Ribbon Panel on MR Safety et al. ACR guidance document for safe MR practices: 2007.  AJR Am J Roentgenol. 2007;  188 (6) 1447-1474
  • 4 ACOG committee opinion guidelines for diagnostic imaging during pregnancy.  Obstet Gynecol. 2004;  104 (3) 647-651
  • 5 Webb J A, Thomsen H S, Morcos S K. Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) . The use of iodinated and gadolinium contrast media during pregnancy and lactation.  Eur Radiol. 2005;  15 (6) 1234-1240
  • 6 Wagner L K, Lester R G, Saldana L R. Exposure of the Pregnant Patient to Diagnostic Radiations: A Guide to Medical Management. Philadelphia, PA: Lippincott; 1985: 19-223
  • 7 Berlin L. Radiation exposure and the pregnant patient.  AJR Am J Roentgenol. 1996;  167 (6) 1377-1379
  • 8 Damilakis J, Prassopoulos P, Perisinakis K, Faflia C, Gourtsoyiannis N. CT of the sacroiliac joints. Dosimetry and optimal settings for a high-resolution technique.  Acta Radiol. 1997;  38 (5) 870-875
  • 9 Damilakis J, Perisinakis K, Voloudaki A, Gourtsoyiannis N. Estimation of fetal radiation dose from computed tomography scanning in late pregnancy: depth-dose data from routine examinations.  Invest Radiol. 2000;  35 (9) 527-533
  • 10 Wagner L K, Archer B R, Zeck O F. Conceptus dose from two state-of-the-art CT scanners.  Radiology. 1986;  159 (3) 787-792
  • 11 Mole R H. Irradiation of the embryo and fetus.  Br J Radiol. 1987;  60 (709) 17-31
  • 12 Stewart A WJ, Giles D, Hewitt D. Malignant disease in childhood and diagnostic irradiation in utero.  Lancet. 1956;  2 447
  • 13 Roberts P J, Given-Wilson R, Gifford D, Bryan G. Pregnancy and work in diagnostic imaging. Report of a Joint Working Party of the Royal College of Radiologists and British Institute of Radiology. London: British Institute of Radiology; 1992
  • 14 Mole R H. Childhood cancer after prenatal exposure to diagnostic X-ray examinations in Britain.  Br J Cancer. 1990;  62 (1) 152-168
  • 15 United Nations Scientific Committee on the Effects of Atomic Radiation .Ionizing radiation: levels and effects. 1972 Report to the General Assembly, with annexes. Vol. II: Effects. New York, NY: United Nations; 1972
  • 16 Muirhead C R, Cox R, Stather J W et al.. Estimates of late radiation risks to the UK population. Documents of the NRPB.  Chilton. 1993;  4 (4) 17-157
  • 17 Ginsberg J S, Hirsh J, Rainbow A J, Coates G. Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease.  Thromb Haemost. 1989;  61 (2) 189-196
  • 18 Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation.  Br J Radiol. 1997;  70 130-139
  • 19 Gilman E A, Kneale G W, Knox E G, Stewart A M. Pregnancy X-rays and childhood cancers: effects of exposure age and radiation dose.  J Radiol Prot. 1988;  8 3-8
  • 20 Benjamin S A, Lee A C, Angleton G M et al.. Neoplasms in young dogs after perinatal irradiation.  J Natl Cancer Inst. 1986;  77 (2) 563-571
  • 21 Nelson J A, Livingston G K, Moon R G. Mutagenic evaluation of radiographic contrast media.  Invest Radiol. 1982;  17 (2) 183-185
  • 22 Morisetti A, Tirone P, Luzzani F, de Haën C. Toxicologic safety assessment of iomeprol, a new x-ray contrast agent.  Eur J Radiol. 1994;  18 21-31
  • 23 Ralston W H, Robbins M S, James P. Reproductive, developmental, and genetic toxicity of ioversol.  Invest Radiol. 1989;  24 16-22
  • 24 Rodesch F, Camus M, Ermans A M, Dodion J, Delange F. Adverse effect of amniofetography on fetal thyroid function.  Am J Obstet Gynecol. 1976;  126 (6) 723-726
  • 25 Bona G, Zaffaroni M, Defilippi C, Gallina M R, Mostert M. Effects of iopamidol on neonatal thyroid function.  Eur J Radiol. 1992;  14 (1) 22-25
  • 26 Russell L B, Russell W L. An analysis of the changing radiation response of the developing mouse embryo.  J Cell Physiol Suppl. 1954;  43 (Suppl. 1) 103-149
  • 27 Brent R L, Ghorson R O. Radiation exposure in pregnancy.  Curr Probl Radiol. 1972;  2 1-48
  • 28 Blot W J, Miller R W. Mental retardation following in utero exposure to the atomic bombs of Hiroshima and Nagasaki.  Radiology. 1973;  106 (3) 617-619
  • 29 Yamazaki J N, Schull W J. Perinatal loss and neurological abnormalities among children of the atomic bomb. Nagasaki and Hiroshima revisited, 1949 to 1989.  JAMA. 1990;  264 (5) 605-609
  • 30 Otake M, Schull W J. In utero exposure to A-bomb radiation and mental retardation; a reassessment.  Br J Radiol. 1984;  57 (677) 409-414
  • 31 Dekaban A S. Abnormalities in children exposed to x-radiation during various stages of gestation: tentative timetable of radiation injury to the human fetus. I.  J Nucl Med. 1968;  9 (9) 471-477
  • 32 Stewart A, Kneale G W. Radiation dose effects in relation to obstetric x-rays and childhood cancers.  Lancet. 1970;  1 (7658) 1185-1188
  • 33 Wakeford R, Little M P. Risk coefficients for childhood cancer after intrauterine irradiation: a review.  Int J Radiat Biol. 2003;  79 (5) 293-309
  • 34 Hall E J, Giaccia A J. Radiobiology for the Radiologist. Philadelphia; Lippincott, Williams, and Wilkins, 2006
  • 35 Osei E K, Faulkner K. Fetal doses from radiological examinations.  Br J Radiol. 1999;  72 (860) 773-780
  • 36 Heinrichs W L, Fong P, Flannery M et al.. Midgestational exposure of pregnant BALB/c mice to magnetic resonance imaging conditions.  Magn Reson Imaging. 1988;  6 (3) 305-313
  • 37 Tyndall D A, Sulik K K. Effects of magnetic resonance imaging on eye development in the C57BL/6J mouse.  Teratology. 1991;  43 (3) 263-275
  • 38 Yip Y P, Capriotti C, Talagala S L, Yip J W. Effects of MR exposure at 1.5 T on early embryonic development of the chick.  J Magn Reson Imaging. 1994;  4 (5) 742-748
  • 39 Kanal E, Shellock F G, Talagala L. Safety considerations in MR imaging.  Radiology. 1990;  176 (3) 593-606
  • 40 Baker P N, Johnson I R, Harvey P R, Gowland P A, Mansfield P. A three-year follow-up of children imaged in utero with echo-planar magnetic resonance.  Am J Obstet Gynecol. 1994;  170 (1 Pt 1) 32-33
  • 41 Glover P, Hykin J, Gowland P, Wright J, Johnson I, Mansfield P. An assessment of the intrauterine sound intensity level during obstetric echo-planar magnetic resonance imaging.  Br J Radiol. 1995;  68 (814) 1090-1094
  • 42 Kittner S J, Stern B J, Feeser B R et al.. Pregnancy and the risk of stroke.  N Engl J Med. 1996;  335 (11) 768-774
  • 43 Wilterdink J L, Easton J D. Cerebral ischemia in pregnancy.  Adv Neurol. 2002;  90 51-62
  • 44 Wilterdink J L, Feldmann E. Intracranial hemorrhage.  Adv Neurol. 2002;  90 63-74
  • 45 Manzione J, Newman G C, Shapiro A, Santo-Ocampo R. Diffusion- and perfusion-weighted MR imaging of dural sinus thrombosis.  AJNR Am J Neuroradiol. 2000;  21 (1) 68-73
  • 46 Ducreux D, Oppenheim C, Vandamme X et al.. Diffusion-weighted imaging patterns of brain damage associated with cerebral venous thrombosis.  AJNR Am J Neuroradiol. 2001;  22 (2) 261-268
  • 47 Mullins M E, Grant P E, Wang B, Gonzalez R G, Schaefer P W. Parenchymal abnormalities associated with cerebral venous sinus thrombosis: assessment with diffusion-weighted MR imaging.  AJNR Am J Neuroradiol. 2004;  25 (10) 1666-1675
  • 48 Bateman B T, Schumacher H C, Bushnell C D et al.. Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome.  Neurology. 2006;  67 (3) 424-429
  • 49 Witlin A G, Friedman S A, Egerman R S, Frangieh A Y, Sibai B M. Cerebrovascular disorders complicating pregnancy—beyond eclampsia.  Am J Obstet Gynecol. 1997;  176 (6) 1139-1145 discussion 1145-1148
  • 50 Moodley J, Kalane G. A review of the management of eclampsia: practical issues.  Hypertens Pregnancy. 2006;  25 (2) 47-62
  • 51 Koch S, Rabinstein A, Falcone S, Forteza A. Diffusion-weighted imaging shows cytotoxic and vasogenic edema in eclampsia.  AJNR Am J Neuroradiol. 2001;  22 (6) 1068-1070
  • 52 Loureiro R, Leite C C, Kahhale S et al.. Diffusion imaging may predict reversible brain lesions in eclampsia and severe preeclampsia: initial experience.  Am J Obstet Gynecol. 2003;  189 (5) 1350-1355
  • 53 Finocchi V, Bozzao A, Bonamini M et al.. Magnetic resonance imaging in posterior reversible encephalopathy syndrome: report of three cases and review of literature.  Arch Gynecol Obstet. 2005;  271 (1) 79-85
  • 54 Shah A K, Whitty J E. Brain MRI in peripartum seizures: usefulness of combined T2 and diffusion weighted MR imaging.  J Neurol Sci. 1999;  166 (2) 122-125
  • 55 Provenzale J M, Petrella J R, Cruz Jr L CH, Wong J C, Engelter S, Barboriak D P. Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome.  AJNR Am J Neuroradiol. 2001;  22 (8) 1455-1461
  • 56 Hinchey J, Chaves C, Appignani B et al.. A reversible posterior leukoencephalopathy syndrome.  N Engl J Med. 1996;  334 (8) 494-500
  • 57 Covarrubias D J, Luetmer P H, Campeau N G. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images.  AJNR Am J Neuroradiol. 2002;  23 (6) 1038-1048
  • 58 Schaefer P W, Buonanno F S, Gonzalez R G, Schwamm L H. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia.  Stroke. 1997;  28 (5) 1082-1085
  • 59 Ay H, Buonanno F S, Schaefer P W et al.. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI.  Neurology. 1998;  51 (5) 1369-1376
  • 60 D'Aprile P, Farchi G, Pagliarulo R, Carella A. Thrombotic thrombocytopenic purpura: MR demonstration of reversible brain abnormalities.  AJNR Am J Neuroradiol. 1994;  15 (1) 19-20
  • 61 Ruggenenti P, Remuzzi G. The pathophysiology and management of thrombotic thrombocytopenic purpura.  Eur J Haematol. 1996;  56 (4) 191-207
  • 62 Bakshi R, Shaikh Z A, Bates V E, Kinkel P R. Thrombotic thrombocytopenic purpura: brain CT and MRI findings in 12 patients.  Neurology. 1999;  52 (6) 1285-1288
  • 63 Singhal A B. Postpartum angiopathy with reversible posterior leukoencephalopathy.  Arch Neurol. 2004;  61 (3) 411-416
  • 64 Neudecker S, Stock K, Krasnianski M. Call-Fleming postpartum angiopathy in the puerperium: a reversible cerebral vasoconstriction syndrome.  Obstet Gynecol. 2006;  107 (2 Pt 2) 446-449
  • 65 Call G K, Fleming M C, Sealfon S, Levine H, Kistler J P, Fisher C M. Reversible cerebral segmental vasoconstriction.  Stroke. 1988;  19 (9) 1159-1170
  • 66 Singhal A B, Caviness V S, Begleiter A F, Mark E J, Rordorf G, Koroshetz W J. Cerebral vasoconstriction and stroke after use of serotonergic drugs.  Neurology. 2002;  58 (1) 130-133
  • 67 Kanaan I, Jallu A, Kanaan H. Management strategy for meningioma in pregnancy: A clinical study.  Skull Base. 2003;  13 (4) 197-203
  • 68 Mamelak A N, Withers G J, Wang X. Choriocarcinoma brain metastasis in a patient with viable intrauterine pregnancy. Case report.  J Neurosurg. 2002;  97 (2) 477-481
  • 69 Biousse V, Newman N J, Oyesiku N M. Precipitating factors in pituitary apoplexy.  J Neurol Neurosurg Psychiatry. 2001;  71 (4) 542-545
  • 70 Masding M G, Lees P D, Gawne-Cain M L, Sandeman D D. Visual field compression by a non-secreting pituitary tumour during pregnancy.  J R Soc Med. 2003;  96 (1) 27-28
  • 71 Keleştimur F. Sheehan's syndrome.  Pituitary. 2003;  6 (4) 181-188
  • 72 Stelmach M, O'Day J. Rapid change in visual fields associated with suprasellar lymphocytic hypophysitis.  J Clin Neuroophthalmol. 1991;  11 (1) 19-24
  • 73 Flanagan D E, Ibrahim A E, Ellison D W, Armitage M, Gawne-Cain M, Lees P D. Inflammatory hypophysitis - the spectrum of disease.  Acta Neurochir (Wien). 2002;  144 (1) 47-56
  • 74 McCutcheon I E, Oldfield E H. Lymphocytic adenohypophysitis presenting as infertility. Case report.  J Neurosurg. 1991;  74 (5) 821-826
  • 75 Horvath E, Vidal S, Syro L V, Kovacs K, Smyth H S, Uribe H. Severe lymphocytic adenohypophysitis with selective disappearance of prolactin cells: a histologic, ultrastructural and immunoelectron microscopic study.  Acta Neuropathol. 2001;  101 (6) 631-637
  • 76 Miyagi K, Shingaki T, Ito K et al.. [Lymphocytic infundibulo-hypophysitis with diabetes insipidus as a new clinical entity: a case report and review of the literature].  No Shinkei Geka. 1997;  25 (2) 169-175
  • 77 Ikeda H, Okudaira Y. Spontaneous regression of pituitary mass in temporal association with pregnancy.  Neuroradiology. 1987;  29 (5) 488-492
  • 78 Ikeda H, Yoshimoto T. Visual disturbances in patients with pituitary adenoma.  Acta Neurol Scand. 1995;  92 (2) 157-160
  • 79 Saeki N, Uchino Y, Murai H et al.. MR imaging study of edema-like change along the optic tract in patients with pituitary region tumors.  AJNR Am J Neuroradiol. 2003;  24 (3) 336-342
  • 80 Arita K, Uozumi T, Yano T et al.. MRI visualization of complete bilateral optic nerve involvement by pituitary adenoma: a case report.  Neuroradiology. 1993;  35 (7) 549-550
  • 81 Gallucci M, Bozzao A, Splendiani A, Masciocchi C, Passariello R. Wernicke encephalopathy: MR findings in five patients.  AJNR Am J Neuroradiol. 1990;  11 (5) 887-892
  • 82 Chung S P, Kim S W, Yoo I S, Lim Y S, Lee G. Magnetic resonance imaging as a diagnostic adjunct to Wernicke encephalopathy in the ED.  Am J Emerg Med. 2003;  21 (6) 497-502
  • 83 Togay-Işikay C, Yiğit A, Mutluer N. Wernicke's encephalopathy due to hyperemesis gravidarum: an under-recognised condition.  Aust N Z J Obstet Gynaecol. 2001;  41 (4) 453-456
  • 84 Chu K, Kang D W, Kim H J, Lee Y S, Park S H. Diffusion-weighted imaging abnormalities in wernicke encephalopathy: reversible cytotoxic edema?.  Arch Neurol. 2002;  59 (1) 123-127
  • 85 Confavreux C, Hutchinson M, Hours M M, Cortinovis-Tourniaire P, Moreau T. Pregnancy in Multiple Sclerosis Group . Rate of pregnancy-related relapse in multiple sclerosis.  N Engl J Med. 1998;  339 (5) 285-291
  • 86 Soldan S S, Alvarez Retuerto A I, Sicotte N L, Voskuhl R R. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol.  J Immunol. 2003;  171 (11) 6267-6274
  • 87 Sandhu F S, Dillon W P. Spinal epidural abscess: evaluation with contrast-enhanced MR imaging.  AJNR Am J Neuroradiol. 1991;  12 (6) 1087-1093
  • 88 Yonekawa Y, Mehdorn H M, Nishikawa M. Spontaneous spinal epidural hematoma during pregnancy.  Surg Neurol. 1975;  3 (6) 327-328

Joshua P KleinM.D. Ph.D. 

Department of Neurology, Brigham and Women's Hospital

75 Francis Street, Boston, MA 02115

Email: jpklein@partners.org

    >